Clinical Trials in the Category "Hematologic Neoplasms"
Drug Intervention Trials that are Recruiting
Study Title |
Principal Investigator | Disease Category | |
 |
|||
| A Phase I Dose Escalation Study of Weekly SGN-35 Alone and in Combination With Gemcitabine in HL |
Sandra Jeane Horning |
Lymphoma, Hodgkin Disease
Hodgkin Disease Blood Cancer | |
|
|||
| Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia |
Peter L Greenberg |
Leukemia
Bone Marrow Neoplasms | |
|
|||
Other Trials that are Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
| Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors |
Kate R Lorig |
Breast Cancer
Prostatic Neoplasms Colorectal Neoplasms Anal, Colon, and Rectal Cancers Blood Cancer | |
|
|||
| TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD |
Robert Lowsky |
Myeloproliferative Disorders
Blood Cancer Myelodysplastic Syndromes | |
|
|||
| Allogeneic Hematopoietic Cell Transplantation Using TLI/ATG for Older Patients with Hematologic Malignancies |
Robert Lowsky |
Blood Cancer | |
|
|||
| Allogeneic Transplantation From Related Haploidentical Donors in Older Patients with Indolent Hematologic Malignancies |
Robert Lowsky |
Blood Cancer | |
|
|||
Trials not Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
|
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Palifermin (rHuKGF) in the Reduction of Acute Graft Versus Host Disease in Subjects With Hematologic Malignancies Undergoing Allogeneic Marrow/PBPC Transplantation
(Completed) |
Ginna Laport |
Graft vs Host Disease
Blood Cancer | |
|
|||
|
Treatment for Acute Graft-Versus-Host Disease
(No longer recruiting) |
Laura Johnston |
Graft vs Host Disease
Blood Cancer | |
|
|||
|
Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors
(No longer recruiting) |
Laura Johnston |
Blood Cancer | |
|
|||
|
Mixed Chimera Allo Transplantation in Multiple Myeloma
(No longer recruiting) |
Wen-Kai Weng |
Blood Cancer
Multiple Myeloma | |
|
|||
| The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials. Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials. |
Trial Administration